As of close of business last night, Atyr Pharma Inc’s stock clocked out at $2.02, up 1.00% from its previous closing price of $2.00. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 904050 shares were traded.
Ratios:
To gain a deeper understanding of LIFE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.27 and its Current Ratio is at 6.27. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
On October 12, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $22.
On September 21, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $19.Piper Sandler initiated its Overweight rating on September 21, 2021, with a $19 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 06 ’24 when Broadfoot Jill Marie sold 1,590 shares for $1.69 per share. The transaction valued at 2,687 led to the insider holds 20,821 shares of the business.
Shukla Sanjay bought 12,000 shares of LIFE for $14,136 on Dec 12 ’23. The President and CEO now owns 106,173 shares after completing the transaction at $1.18 per share. On Dec 11 ’23, another insider, Shukla Sanjay, who serves as the President and CEO of the company, bought 3,000 shares for $1.17 each. As a result, the insider paid 3,510 and bolstered with 94,173 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIFE now has a Market Capitalization of 136.18M and an Enterprise Value of 53.11M. For the stock, the TTM Price-to-Sale (P/S) ratio is 391.01 while its Price-to-Book (P/B) ratio in mrq is 1.41. Its current Enterprise Value per Revenue stands at 150.44 whereas that against EBITDA is -1.02.
Stock Price History:
Over the past 52 weeks, LIFE has reached a high of $2.70, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 1.7396, while the 200-Day Moving Average is calculated to be 1.6724.
Shares Statistics:
It appears that LIFE traded 517.86K shares on average per day over the past three months and 733.12k shares per day over the past ten days. A total of 67.75M shares are outstanding, with a floating share count of 65.34M. Insiders hold about 3.56% of the company’s shares, while institutions hold 60.44% stake in the company. Shares short for LIFE as of Feb 29, 2024 were 108.23k with a Short Ratio of 0.21, compared to 99.41k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.18% and a Short% of Float of 0.27%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.29, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.75 and -$1.19 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.94, with 5 analysts recommending between -$0.64 and -$1.11.
